deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT02881047

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Ablative Fractional Laser Resurfacing for the Treatment of Scars and Contractures Caused by Sclerotic Skin Changes Chronic Graft Versus Host Disease

Sponsor: Abramson Cancer Center at Penn Medicine

Conditions Subjects With Severe, Refractory Sclerotic Skin Changes
Interventions CO2 Laser Skin Biopsy Ultrasound
Updated 9 times since 2017 Last updated: Apr 6, 2020 Started: Nov 11, 2013 Primary completion: Aug 31, 2016 Completion: Aug 19, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Abramson Cancer Center at Penn Medicine

See all terminations from Abramson Cancer Center at Penn Medicine

This NA trial investigates Subjects With Severe, Refractory Sclerotic Skin Changes and is currently terminated or withdrawn. Abramson Cancer Center at Penn Medicine leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotActive Not Recruiting~Oct 2018 – ~May 2020 · 19 months · monthly snapshotActive Not Recruiting~May 2020 – ~Jan 2021 · 8 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshotTerminated~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Apr 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Dec 2021 — Apr 2023 [monthly]

    Terminated NA

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

▶ Show 4 earlier versions

  1. May 2020 — Jan 2021 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  2. Oct 2018 — May 2020 [monthly]

    Active Not Recruiting NA

  3. Jun 2018 — Oct 2018 [monthly]

    Active Not Recruiting NA

  4. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abramson Cancer Center at Penn Medicine
Data source: Abramson Cancer Center at Penn Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations